GSK Names Six Directors For Haleon Board Ahead Of Demerger

GlaxoSmithKline (GSK) has unveiled six appointments to the board of Haleon, the new independent Consumer Healthcare company that will be formed following its planned demerger in July 2022. Following the recent hiring of ex-Tesco CEO Sir Dave Lewis as Haleon's Chairman, the board appointments include the transition of two GSK Non-Executive Directors - Vindi Banga and Dame Vivienne Cox - and three new external appointees. The external hires include Tracy Clarke, a former Chief Executive at banking group Standard Chartered, and Deirdre Mahlan, the previous head of North American operations at Diageo. John Young is also joining from Pfizer, which…